Kaleido Biosciences (EM)【KLDO】銘柄情報

Kaleido Biosciences Inc (EM) (KLDO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0001

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.35

時価総額

4.262k

前日終値

0.0001

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 2,877

発行済株式数

42,622,559

配当利回り

PER

-0

1 株当たり利益 (EPS)

-2.16

歳入

1.1M

純利益

-90.29M

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-1... Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of ulcerative colitis, psoriasis, atopic immune disease, chronic obstructive pulmonary disease pathogens, and immuno-oncology. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

kaleido.com

本社

Lexington, United States

設立

2026

Kaleido Biosciences Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker KLDO. The last closing price for Kaleido Biosciences (EM) was US$0. Over the last year, Kaleido Biosciences (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.35.

Kaleido Biosciences (EM) currently has 42,622,559 shares in issue. The market capitalisation of Kaleido Biosciences (EM) is US$4,262.26 . Kaleido Biosciences (EM) has a price to earnings ratio (PE ratio) of -0.00.

Correction: QED Connect, Inc. Signs Agreement to Acquire 75% of Kaleidoscope Venture Capital, Inc.

Correction: QED Connect, Inc. Signs Agreement to Acquire 75% of Kaleidoscope Venture Capital, Inc. PR Newswire MANCHESTER, N.H., Oct. 7, 2011...

QED Connect, Inc., Signs Letter of Intent to Acquire 75% of Kaleidoscope Venture Capital, Inc.

QED Connect, Inc., Signs Letter of Intent to Acquire 75% of Kaleidoscope Venture Capital, Inc. PR Newswire MANCHESTER, N.H., Oct. 7, 2011...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.0001	0.20005	0.0001	7046	0.0001	CS
4	0	0	0.0001	0.20005	0.0001	4036	0.00012762	CS
12	0	0	0.0001	0.20005	0.0001	2880	0.00011629	CS
26	9.9E-5	9900	1.0E-6	0.20005	1.0E-6	27762	8.42E-5	CS
52	0	0	0.0001	0.35	1.0E-6	20378	0.0003907	CS
156	0	0	0.0001	0.35	1.0E-6	10094	0.00033886	CS
260	-0.0018	-94.7368421053	0.0019	0.35	1.0E-6	81795	0.06054595	CS